Biocon

Biocon is India's largest biopharmaceutical company and one of the world's leading biosimilars manufacturers. Founded by Kiran Mazumdar-Shaw, Biocon has developed a portfolio of biosimilar products for diabetes, oncology, and immunology that serve patients in over 120 countries. The company's subsidiary Biocon Biologics merged with Viatris's biosimilar business to create a global biosimilars powerhouse.

Biocon is making expensive biologic drugs accessible to millions of patients worldwide through affordable biosimilars, reshaping global pharmaceutical economics.